Relationships of CDXs and Apical Sodium-dependent Bile Acid Transporter in Barrett's Esophagus
Overview
Authors
Affiliations
Barrett's esophagus (BE) is characterized by intestinal metaplasia with the differentiated epithelium replaced by another type of epithelium morphologically similar to normal intestinal epithelium. The metaplasia is preceded by bile and acid reflux into the esophagus. BE is a premalignant condition associated with increased risk of esophageal cancer, especially esophageal adenocarcinoma. The Caudal-related homeodomain transcription factors Caudal-related homeodomain transcription factor CDX1 and CDX2 are expressed exclusively in the small and large intestine, playing important roles in proliferation and differentiation of intestinal epithelial cells. Ectopic expression of CDX1 and CDX2 occurs in BE. The apical sodium-dependent bile acid transporter (ASBT) is expressed primarily in terminal ileum where it is a key factor for intestinal reabsorption of bile salts. In addition to upregulation of CDX1 and CDX2, ASBT expression is up-regulated in BE. Furthermore, both CDX1/CDX2 and ASBT expressions are down-regulated in high-grade esophageal dysplasia. The alteration of the above-mentioned factors calls for attention: what is the relationship between CDXs and ASBT aberrant expression in BE? In this commentary, we discuss this issue on basis of the recent study done by Ma et al.
Bile Acid Sequestrant Use and Gastric Cancer: A National Retrospective Cohort Analysis.
Canakis A, Lee A, Halvorson A, Noto J, Peek Jr R, Wilson O Clin Transl Gastroenterol. 2023; 14(12):e00596.
PMID: 37606521 PMC: 10749703. DOI: 10.14309/ctg.0000000000000596.
Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?.
Alsalahi O, Dobrian A Front Oncol. 2015; 4:373.
PMID: 25621278 PMC: 4288325. DOI: 10.3389/fonc.2014.00373.
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.
Yan L, Wei W, Xie Y, Xiao Q World J Gastroenterol. 2014; 20(14):3960-6.
PMID: 24744585 PMC: 3983451. DOI: 10.3748/wjg.v20.i14.3960.
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
Yan L, Wang X, Yang J, Lian C, Kong F, Wei W World J Gastroenterol. 2013; 19(26):4155-65.
PMID: 23864778 PMC: 3710417. DOI: 10.3748/wjg.v19.i26.4155.